Gilbert S, Hatchett R. No one is safe until we are all safe. Sci Transl Med. 2021;13:eabl9900.

Article  CAS  PubMed  Google Scholar 

Msomi N, Lessells R, Mlisana K, de Oliveira T. Africa: tackle HIV and COVID-19 together. Nature. 2021;600:33–6.

Article  CAS  PubMed  Google Scholar 

Etienne CF. COVID-19 has revealed a pandemic of inequality. Nat Med. 2022;28:17.

Article  CAS  PubMed  Google Scholar 

Graham BS. Rapid COVID-19 vaccine development. Science. 2020;368:945–6.

Article  CAS  PubMed  Google Scholar 

Maxmen A. Unseating big pharma: the radical plan for vaccine equity. Nature. 2022;607:226–33.

Article  CAS  PubMed  Google Scholar 

Malone RW, Felgner PL, Verma IM. Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci USA. 1989;86:6077–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang L, Zhang L, Li W, Li S, Wen J, Li H, et al. Advances in development of mRNA-based therapeutics. Curr Top Microbiol Immunol. 2022;440:147–66.

PubMed  Google Scholar 

Kowalski PS, Rudra A, Miao L, Anderson DG. Delivering the messenger: advances in technologies for therapeutic mRNA Delivery. Mol Ther. 2019;27:710–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akamine CM, El Sahly HM. Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 - a review. Transl Res. 2022;242:1–19.

Article  CAS  PubMed  Google Scholar 

Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403–16.

Article  CAS  PubMed  Google Scholar 

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–15.

Article  CAS  PubMed  Google Scholar 

Teijaro JR, Farber DL. COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol. 2021;21:195–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Muramatsu H, Lam K, Bajusz C, Laczko D, Kariko K, Schreiner P, et al. Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine. Mol Ther. 2022;30:1941–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koh KJ, Liu Y, Lim SH, Loh XJ, Kang L, Lim CY, et al. Formulation, characterization and evaluation of mRNA-loaded dissolvable polymeric microneedles (RNApatch). Sci Rep. 2018;8:11842.

Article  PubMed  PubMed Central  Google Scholar 

Vander Straeten A, Sarmadi M, Daristotle JL, Kanelli M, Tostanoski LH, Collins J, et al. A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines. Nat Biotechnol. 2024;42:510–7.

Article  Google Scholar 

Ho NT, Hughes SG, Ta VT, Phan LT, Do Q, Nguyen TV, et al. Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials. Nat Commun. 2024;15:4081.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pollock KM, Cheeseman HM, Szubert AJ, Libri V, Boffito M, Owen D, et al. Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial. eClinicalMedicine. 2022;44:101262.

Article  PubMed  PubMed Central  Google Scholar 

Low JG, de Alwis R, Chen S, Kalimuddin S, Leong YS, Mah TKL, et al. A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine. NPJ Vaccines. 2022;7:161.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ely A, Singh P, Smith TS, Arbuthnot P. In vitro transcribed mRNA for expression of designer nucleases: advantages as a novel therapeutic for the management of chronic HBV infection. Adv Drug Deliv Rev. 2021;168:134–46.

Article  CAS  PubMed  Google Scholar 

Blakney AK, McKay PF, Bouton CR, Hu K, Samnuan K, Shattock RJ. Innate inhibiting proteins enhance expression and immunogenicity of self-amplifying RNA. Mol Ther. 2021;29:1174–85.

Article  CAS  PubMed  Google Scholar 

Mc Cafferty S, De Temmerman J, Kitada T, Becraft JR, Weiss R, Irvine DJ, et al. In vivo validation of a reversible small molecule-based switch for synthetic self-amplifying mRNA regulation. Mol Ther. 2021;29:1164–73.

Article  Google Scholar 

Wold WS, Toth K. Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. Curr Gene Ther. 2013;13:421–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab. 2003;80:148–58.

Article  CAS  PubMed  Google Scholar 

Mendonca SA, Lorincz R, Boucher P, Curiel DT. Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic. NPJ Vaccines. 2021;6:97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384:2092–101.

Article  CAS  PubMed  Google Scholar 

Muir KL, Kallam A, Koepsell SA, Gundabolu K. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. N Engl J Med. 2021;384:1964–5.

Article  CAS  PubMed  Google Scholar 

Schultz NH, Sorvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021;384:2124–30.

Article  CAS  PubMed  Google Scholar 

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Understanding Viral Vector COVID-19 Vaccines. 2022. https://stacks.cdc.gov/view/cdc/115410.

Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet. 2008;372:1881–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

DeFrancesco L. Preparing for the next plague. Nat Biotechnol. 2021;39:1491–6.

Article  CAS  PubMed  Google Scholar 

Mallapaty S. The pathogens that could spark the next pandemic. Nature. 2024;632:488.

Article  PubMed  Google Scholar 

Park YJ, De Marco A, Starr TN, Liu Z, Pinto D, Walls AC, et al. Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry. Science. 2022;375:449–54.

Article  CAS  PubMed  PubMed Central